{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T23:16:21Z","timestamp":1792019781370,"version":"4.4.0"},"reference-count":38,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2006,3,1]],"date-time":"2006-03-01T00:00:00Z","timestamp":1141171200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"vor","delay-in-days":5298,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Lipid Research"],"published-print":{"date-parts":[[2006,3]]},"DOI":"10.1194\/jlr.m500322-jlr200","type":"journal-article","created":{"date-parts":[[2005,12,8]],"date-time":"2005-12-08T01:35:04Z","timestamp":1134005704000},"page":"521-529","source":"Crossref","is-referenced-by-count":42,"title":["LDL receptor deficiency or apoE mutations prevent remnant clearance and induce hypertriglyceridemia in mice"],"prefix":"10.1016","volume":"47","author":[{"given":"Kyriakos E.","family":"Kypreos","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vassilis I.","family":"Zannis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1194\/jlr.M500322-JLR200_bib1","first-page":"11","article-title":"Human apolipoprotein E isoprotein subclasses are genetically determined","volume":"33","author":"Zannis","year":"1981","journal-title":"Am. J. Hum. Genet."},{"key":"10.1194\/jlr.M500322-JLR200_bib2","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/0092-8674(92)90362-G","article-title":"Severe hypercholesterolemia and atherosclerosis in apolipoprotein E-deficient mice created by homologous recombination in ES cells","volume":"71","author":"Plump","year":"1992","journal-title":"Cell."},{"key":"10.1194\/jlr.M500322-JLR200_bib3","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1126\/science.1411543","article-title":"Spontaneous hypercholesterolemia and arterial lesions in mice lacking apolipoprotein E","volume":"258","author":"Zhang","year":"1992","journal-title":"Science."},{"key":"10.1194\/jlr.M500322-JLR200_bib4","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1172\/JCI109988","article-title":"Radioimmunoassay of human arginine-rich apolipoprotein, apoprotein E. Concentration in blood plasma and lipoproteins as affected by apoprotein E-3 deficiency","volume":"66","author":"Havel","year":"1980","journal-title":"J. Clin. Invest."},{"key":"10.1194\/jlr.M500322-JLR200_bib5","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1096\/fj.00-0882fje","article-title":"Analysis of the structure and function relationship of the human apolipoprotein E in vivo, using adenovirus-mediated gene transfer","volume":"15","author":"Kypreos","year":"2001","journal-title":"FASEB J."},{"key":"10.1194\/jlr.M500322-JLR200_bib6","doi-asserted-by":"crossref","first-page":"6027","DOI":"10.1021\/bi002414a","article-title":"The amino-terminal 1\u2013185 domain of apoE promotes the clearance of lipoprotein remnants in vivo. The carboxy-terminal domain is required for induction of hyperlipidemia in normal and apoE-deficient mice","volume":"40","author":"Kypreos","year":"2001","journal-title":"Biochemistry."},{"key":"10.1194\/jlr.M500322-JLR200_bib7","doi-asserted-by":"crossref","first-page":"19778","DOI":"10.1074\/jbc.M100418200","article-title":"Domains of apolipoprotein E contributing to triglyceride and cholesterol homeostasis in vivo. Carboxyl-terminal region 203\u2013299 promotes hepatic very low density lipoprotein-triglyceride secretion","volume":"276","author":"Kypreos","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1194\/jlr.M500322-JLR200_bib8","doi-asserted-by":"crossref","first-page":"9841","DOI":"10.1021\/bi0271796","article-title":"Molecular mechanisms of type III hyperlipoproteinemia: the contribution of the carboxy-terminal domain of apoE can account for the dyslipidemia that is associated with the E2\/E2 phenotype","volume":"42","author":"Kypreos","year":"2003","journal-title":"Biochemistry."},{"key":"10.1194\/jlr.M500322-JLR200_bib9","doi-asserted-by":"crossref","first-page":"26388","DOI":"10.1074\/jbc.273.41.26388","article-title":"Overexpression and accumulation of apolipoprotein E as a cause of hypertriglyceridemia","volume":"273","author":"Huang","year":"1998","journal-title":"J. Biol. Chem."},{"key":"10.1194\/jlr.M500322-JLR200_bib10","doi-asserted-by":"crossref","first-page":"4431","DOI":"10.1073\/pnas.91.10.4431","article-title":"The two-receptor model of lipoprotein clearance: tests of the hypothesis in \u201cknockout\u201d mice lacking the low density lipoprotein receptor, apolipoprotein E, or both proteins","volume":"91","author":"Ishibashi","year":"1994","journal-title":"Proc. Natl. Acad. Sci. USA."},{"key":"10.1194\/jlr.M500322-JLR200_bib11","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1097\/00041433-200404000-00008","article-title":"Probing the pathways of chylomicron and HDL metabolism using adenovirus-mediated gene transfer","volume":"15","author":"Zannis","year":"2004","journal-title":"Curr. Opin. Lipidol."},{"key":"10.1194\/jlr.M500322-JLR200_bib12","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1194\/jlr.M200313-JLR200","article-title":"Hyperlipidemia in APOE2 transgenic mice is ameliorated by a truncated apoE variant lacking the C-terminal domain","volume":"44","author":"Gerritsen","year":"2003","journal-title":"J. Lipid Res."},{"key":"10.1194\/jlr.M500322-JLR200_bib13","doi-asserted-by":"crossref","first-page":"6276","DOI":"10.1074\/jbc.M413458200","article-title":"Generation of a recombinant apolipoprotein E variant with improved biological functions: hydrophobic residues (LEU-261, TRP-264, PHE-265, LEU-268, VAL-269) of apoE can account for the apoE-induced hypertriglyceridemia","volume":"280","author":"Kypreos","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1194\/jlr.M500322-JLR200_bib14","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1021\/bi00601a013","article-title":"Enhanced binding by cultured human fibroblasts of apo-E-containing lipoproteins as compared with low density lipoproteins","volume":"17","author":"Innerarity","year":"1978","journal-title":"Biochemistry."},{"key":"10.1194\/jlr.M500322-JLR200_bib15","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1097\/00041433-199504000-00007","article-title":"Lipoprotein and receptor interactions in vivo","volume":"6","author":"Herz","year":"1995","journal-title":"Curr. Opin. Lipidol."},{"key":"10.1194\/jlr.M500322-JLR200_bib16","first-page":"37","article-title":"Characterization and immunohistochemical localization of alpha 2-macroglobulin receptor (low-density lipoprotein receptor-related protein) in human brain","volume":"141","author":"Wolf","year":"1992","journal-title":"Am. J. Pathol."},{"key":"10.1194\/jlr.M500322-JLR200_bib17","doi-asserted-by":"crossref","first-page":"9252","DOI":"10.1073\/pnas.89.19.9252","article-title":"Rabbit very low density lipoprotein receptor: a low density lipoprotein receptor-like protein with distinct ligand specificity","volume":"89","author":"Takahashi","year":"1992","journal-title":"Proc. Natl. Acad. Sci. USA."},{"key":"10.1194\/jlr.M500322-JLR200_bib18","doi-asserted-by":"crossref","first-page":"8373","DOI":"10.1074\/jbc.271.14.8373","article-title":"Human apolipoprotein E receptor 2. A novel lipoprotein receptor of the low density lipoprotein receptor family predominantly expressed in brain","volume":"271","author":"Kim","year":"1996","journal-title":"J. Biol. Chem."},{"key":"10.1194\/jlr.M500322-JLR200_bib19","doi-asserted-by":"crossref","first-page":"21149","DOI":"10.1074\/jbc.M200658200","article-title":"Reconstituted discoidal apoE-phospholipid particles are ligands for the scavenger receptor BI. The amino-terminal 1\u2013165 domain of apoE suffices for receptor binding","volume":"277","author":"Li","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1194\/jlr.M500322-JLR200_bib20","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1172\/JCI1240","article-title":"Inducible inactivation of hepatic LRP gene by cre-mediated recombination confirms role of LRP in clearance of chylomicron remnants","volume":"101","author":"Rohlmann","year":"1998","journal-title":"J. Clin. Invest."},{"key":"10.1194\/jlr.M500322-JLR200_bib21","doi-asserted-by":"crossref","first-page":"2173","DOI":"10.1016\/S0022-2275(20)34932-4","article-title":"Hepatic uptake of chylomicron remnants","volume":"38","author":"Cooper","year":"1997","journal-title":"J. Lipid Res."},{"key":"10.1194\/jlr.M500322-JLR200_bib22","series-title":"The Metabolic and Molecular Bases of Inherited Disease","first-page":"2863","article-title":"Familial hypercholesterolemia","author":"Goldstein","year":"2001"},{"key":"10.1194\/jlr.M500322-JLR200_bib23","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1172\/JCI114839","article-title":"Chylomicron remnant clearance from the plasma is normal in familial hypercholesterolemic homozygotes with defined receptor defects","volume":"86","author":"Rubinsztein","year":"1990","journal-title":"J. Clin. Invest."},{"key":"10.1194\/jlr.M500322-JLR200_bib24","doi-asserted-by":"crossref","first-page":"2764","DOI":"10.1016\/S0021-9258(17)42009-6","article-title":"Secretion-capture role for apolipoprotein E in remnant lipoprotein metabolism involving cell surface heparan sulfate proteoglycans","volume":"269","author":"Ji","year":"1994","journal-title":"J. Biol. Chem."},{"key":"10.1194\/jlr.M500322-JLR200_bib25","doi-asserted-by":"crossref","first-page":"2509","DOI":"10.1073\/pnas.95.5.2509","article-title":"A simplified system for generating recombinant adenoviruses","volume":"95","author":"He","year":"1998","journal-title":"Proc. Natl. Acad. Sci. USA."},{"key":"10.1194\/jlr.M500322-JLR200_bib26","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1089\/hum.1996.7.2-215","article-title":"Characterization of 911: a new helper cell line for the titration and propagation of early region 1-deleted adenoviral vectors","volume":"7","author":"Fallaux","year":"1996","journal-title":"Hum. Gene Ther."},{"key":"10.1194\/jlr.M500322-JLR200_bib27","doi-asserted-by":"crossref","first-page":"10406","DOI":"10.1021\/bi027093c","article-title":"Domains of apoE required for binding to apoE receptor 2 and to phospholipids: implications for the functions of apoE in the brain","volume":"42","author":"Li","year":"2003","journal-title":"Biochemistry."},{"key":"10.1194\/jlr.M500322-JLR200_bib28","series-title":"The Metabolic and Molecular Bases of Inherited Disease","first-page":"2835","article-title":"Type III hyperlipoproteinemia (dysbetalipoproteinemia): the role of apolipoprotein E in normal and abnormal lipoprotein metabolism","author":"Mahley","year":"2001"},{"key":"10.1194\/jlr.M500322-JLR200_bib29","doi-asserted-by":"crossref","first-page":"4696","DOI":"10.1073\/pnas.79.15.4696","article-title":"Structural basis for receptor binding heterogeneity of apolipoprotein E from type III hyperlipoproteinemic subjects","volume":"79","author":"Rall","year":"1982","journal-title":"Proc. Natl. Acad. Sci. USA."},{"key":"10.1194\/jlr.M500322-JLR200_bib30","doi-asserted-by":"crossref","first-page":"1962","DOI":"10.1016\/S0021-9258(18)46040-1","article-title":"The functional characteristics of a human apolipoprotein E variant (cysteine at residue 142) may explain its association with dominant expression of type III hyperlipoproteinemia","volume":"267","author":"Horie","year":"1992","journal-title":"J. Biol. Chem."},{"key":"10.1194\/jlr.M500322-JLR200_bib31","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1172\/JCI110978","article-title":"Atypical familial dysbetalipoproteinemia associated with apolipoprotein phenotype E3\/3","volume":"72","author":"Havel","year":"1983","journal-title":"J. Clin. Invest."},{"key":"10.1194\/jlr.M500322-JLR200_bib32","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/0021-9150(94)05393-W","article-title":"Identification of a new apolipoprotein E variant (E2 Arg142\u2192Leu) in type III hyperlipidemia","volume":"112","author":"Richard","year":"1995","journal-title":"Atherosclerosis."},{"key":"10.1194\/jlr.M500322-JLR200_bib33","doi-asserted-by":"crossref","first-page":"10479","DOI":"10.1016\/S0021-9258(18)99249-5","article-title":"Apolipoprotein E-4Philadelphia (Glu13-Lys,Arg145-Cys). Homozygosity for two rare point mutations in the apolipoprotein E gene combined with severe type III hyperlipoproteinemia","volume":"266","author":"Lohse","year":"1991","journal-title":"J. Biol. Chem."},{"key":"10.1194\/jlr.M500322-JLR200_bib34","doi-asserted-by":"crossref","first-page":"13642","DOI":"10.1016\/S0021-9258(18)42261-2","article-title":"Heterozygosity for apolipoprotein E-4Philadelphia(Glu13-Lys, Arg145-Cys) is associated with incomplete dominance of type III hyperlipoproteinemia","volume":"267","author":"Lohse","year":"1992","journal-title":"J. Biol. Chem."},{"key":"10.1194\/jlr.M500322-JLR200_bib35","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1161\/01.ATV.17.5.865","article-title":"The apolipoprotein E2 (Arg145Cys) mutation causes autosomal dominant type III hyperlipoproteinemia with incomplete penetrance","volume":"17","author":"de Villiers","year":"1997","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1194\/jlr.M500322-JLR200_bib36","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1172\/JCI112645","article-title":"Abnormal in vivo metabolism of apolipoprotein E4 in humans","volume":"78","author":"Gregg","year":"1986","journal-title":"J. Clin. Invest."},{"key":"10.1194\/jlr.M500322-JLR200_bib37","doi-asserted-by":"crossref","first-page":"3777","DOI":"10.1182\/blood-2003-11-4051","article-title":"Hepatic low-density lipoproteinreceptor-related protein deficiency in mice increases atherosclerosis independent of plasma cholesterol","volume":"103","author":"Espirito Santo","year":"2004","journal-title":"Blood."},{"key":"10.1194\/jlr.M500322-JLR200_bib38","doi-asserted-by":"crossref","first-page":"4186","DOI":"10.1016\/S0021-9258(18)50713-4","article-title":"Binding of arginine-rich (E) apoprotein after recombination with phospholipid vesicles to the low density lipoprotein receptors of fibroblasts","volume":"254","author":"Innerarity","year":"1979","journal-title":"J. Biol. Chem."}],"container-title":["Journal of Lipid Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022227520336063?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022227520336063?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1194\/jlr.M500322-JLR200","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,20]],"date-time":"2021-11-20T17:36:31Z","timestamp":1637429791000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022227520336063"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,3]]},"references-count":38,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2006,3]]}},"alternative-id":["S0022227520336063"],"URL":"https:\/\/doi.org\/10.1194\/jlr.m500322-jlr200","relation":{},"ISSN":["0022-2275"],"issn-type":[{"value":"0022-2275","type":"print"}],"subject":[],"published":{"date-parts":[[2006,3]]}}}